| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 91.043 | 190.827 | 207.605 | 217.527 | 202.996 | 262.601 | 250.198 | 237.727 | 219.303 |
| Total Income - EUR | - | 91.045 | 191.834 | 207.629 | 217.586 | 203.722 | 262.601 | 250.200 | 243.636 | 231.565 |
| Total Expenses - EUR | - | 76.030 | 178.041 | 161.603 | 214.089 | 116.193 | 115.925 | 139.177 | 167.865 | 140.439 |
| Gross Profit/Loss - EUR | - | 15.016 | 13.793 | 46.026 | 3.497 | 87.529 | 146.676 | 111.022 | 75.771 | 91.126 |
| Net Profit/Loss - EUR | - | 14.278 | 11.875 | 43.950 | 1.720 | 86.890 | 144.155 | 108.520 | 73.394 | 84.046 |
| Employees | - | 5 | 7 | 7 | 8 | 6 | 7 | 6 | 6 | 6 |
Check the financial reports for the company - Euromed Jamgossian Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 8.699 | 6.477 | 15.408 | 14.561 | 14.509 | 10.326 | 5.900 | 1.899 | 5.274 |
| Current Assets | - | 14.517 | 20.293 | 31.142 | 29.365 | 77.603 | 161.063 | 178.318 | 122.896 | 110.926 |
| Inventories | - | 837 | 882 | 1.882 | 9.021 | 3.736 | 20.015 | 18.332 | 17.657 | 13.192 |
| Receivables | - | 61 | 3.971 | 2.497 | 885 | 2.525 | 22.461 | 47.345 | 12.837 | 1.970 |
| Cash | - | 13.618 | 15.440 | 26.763 | 19.460 | 71.342 | 118.587 | 112.641 | 21.645 | 25.421 |
| Shareholders Funds | - | 12.267 | 23.935 | 43.993 | 35.989 | 87.675 | 165.210 | 108.569 | 94.314 | 84.094 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 10.967 | 2.836 | 2.557 | 8.528 | 5.347 | 7.152 | 76.338 | 31.027 | 32.318 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Euromed Jamgossian Srl